CBD Guides

CBD and the grapefruit warning: what UK users need to know

By the Honest CBD Co team · 27th September 2026 · Updated 29th September 2026

Yes. For some prescription medicines, CBD can create the same interaction risk flagged by a grapefruit warning on the packet. If your medicine’s leaflet mentions grapefruit, that’s a signal to speak to your GP or pharmacist before trying CBD, not a footnote to skip past. Both grapefruit and CBD interfere with the enzymes your liver and gut use to break down certain drugs, and that interference can raise or lower the amount of medicine reaching your bloodstream.

TL;DR:

Both grapefruit and CBD inhibit the CYP3A4 enzyme, which can significantly increase blood levels of drugs that rely on this pathway for metabolism.

Medications such as statins, immunosuppressants, certain antidepressants, antiarrhythmics and antiepileptics often carry grapefruit warnings because of potential interactions with CBD.

Clinical trials show real effects: citalopram exposure rose 43% and tacrolimus exposure roughly tripled when taken alongside high-dose CBD.

People on medications with grapefruit warnings should consult their healthcare provider before trying CBD and disclose their full medication list to ensure safety.

UK guidance is cautious here: the FSA advises that pregnant or breastfeeding people should avoid CBD, and that anyone taking medication should get medical advice before using it.

Honest CBD Co

Honestly Made CBD Since 2018

We are a husband-and-wife team in Bolton, making our own CBD oils, capsules and salve in small UK batches since 2018, rated Excellent on Trustpilot across 700+ reviews.

Visit Honest CBD Co

How CBD and grapefruit affect drug metabolism
Medicine classes that commonly carry grapefruit warnings
What the clinical evidence actually shows
Who should avoid CBD, and how much is considered safe
What to do if your medicine has a grapefruit warning
How Honest CBD Co supports safer CBD use
Signs that a CBD and medicine interaction may be happening
If you suspect an interaction, here’s what to do
A cautious, practical view
How Honest CBD Co can help you trial CBD more safely
Sources
FAQ

How CBD and grapefruit affect drug metabolism

Grapefruit and CBD both interact with a family of liver and gut enzymes called cytochrome P450, or CYP450. The most relevant member is CYP3A4, which handles a large share of oral medicines during their first pass through the intestine and liver before they even reach the bloodstream. When something blocks CYP3A4, more of the drug slips through unprocessed, and blood levels climb higher than intended.

Grapefruit inhibits intestinal and hepatic CYP3A4, and peer-reviewed literature lists more than 85 drugs affected by this mechanism, which is why so many medicine leaflets carry the warning. CBD works on a similar cluster of enzymes but with more variation:

CYP3A4 and CYP2C19: CBD can inhibit both, slowing the breakdown of drugs that rely on them, a finding repeated across pharmacology reviews of cannabinoid and drug interactions.
Inhibition versus induction: at some doses CBD inhibits an enzyme, and at others it can induce it, meaning the effect on a given drug isn’t always in the same direction.
UGT enzymes: CBD also affects a separate pathway called UGT, widening the range of medicines it can touch beyond what grapefruit affects.
Individual factors: liver disease, genetic differences in enzyme activity and other medicines being taken at the same time all change how strongly this plays out.

CBD’s effect on CYP3A4, CYP2C19 and UGT enzymes is substrate-specific, meaning it depends on the particular drug involved. That’s why a grapefruit warning is a useful rule of thumb rather than a guarantee that CBD will behave identically.

Medicine classes that commonly carry grapefruit warnings

If your prescription comes with a grapefruit warning, check which class it belongs to, since several common categories are affected. Not every drug within a class carries the warning, so always check your own patient leaflet or ask a pharmacist rather than assuming.

Statins (such as simvastatin and atorvastatin): grapefruit and CBD can both raise blood levels, increasing the risk of muscle-related side effects.
Calcium channel blockers (such as amlodipine and felodipine): used for blood pressure, these rely heavily on CYP3A4 for clearance.
Immunosuppressants (such as tacrolimus and ciclosporin): these have a narrow safety margin, so even modest increases in exposure matter.
SSRIs and other antidepressants (such as citalopram and sertraline): metabolised partly through CYP2C19, a pathway CBD also touches.
Antiepileptics (such as carbamazepine and clobazam): interactions here can affect seizure control in either direction.
Antiarrhythmics (such as amiodarone): used for heart rhythm problems, with a narrow therapeutic window.
Certain pain medicines and antimicrobials: some, though not all, rely on CYP3A4 clearance and may be flagged on the leaflet.

The safest habit is treating the grapefruit line on your patient information leaflet as a direct question for your pharmacist about CBD, not just about citrus.

What the clinical evidence actually shows

The strongest evidence so far comes from controlled trials rather than anecdote, and it points to real, measurable changes in drug exposure.

A clinical trial evaluating CBD alongside citalopram and morphine found that CBD given at 2.5 mg/kg twice daily increased citalopram’s AUC (a measure of total drug exposure) by 43% and its peak concentration by 12%, a meaningful pharmacokinetic interaction.
That same trial found far less interaction with morphine, showing that the risk is drug-specific rather than a blanket effect of taking CBD alongside any prescription.
A phase 1 trial on CBD and tacrolimus found tacrolimus exposure roughly tripling once high-dose CBD reached a steady state, with peak levels more than four times higher, a serious concern for transplant patients on a drug with a narrow safety margin.

A 43% rise in citalopram exposure from CBD at 2.5 mg/kg twice daily is large enough to matter clinically, particularly for SSRIs where side effects and dosing are already finely balanced. It is worth knowing that this trial dose works out at roughly 350mg of CBD a day for an average adult, far more than typical food-supplement use, but lower doses haven’t been proven interaction-free, so the caution stands at any dose.

Not every drug has been studied this closely, and morphine’s relatively muted response in the same trial is a reminder that evidence remains thin for many medicines. Layered on top of this is a practical problem: studies cited in the same paper found around three-quarters of consumer CBD products were over-filled or under-filled compared with what the packaging states. That means even a clinician trying to predict an interaction based on a stated dose may be working from inaccurate information, which is one more reason to buy from a brand with a track record and to tell your clinician the exact product and strength you’re using.

Who should avoid CBD, and how much is considered safe

The UK’s Food Standards Agency advises healthy adults to keep CBD to about 10mg a day. That advice is precautionary rather than a hard limit, and our honest view is that it sits below real-world use: the FSA’s own figure was 70mg a day until autumn 2023, clinical research routinely uses doses in the hundreds of milligrams, and many regular users settle at 25-100mg or more. Where the FSA is firmer, we agree with it: pregnant or breastfeeding people should avoid CBD, and anyone taking medication should get medical advice before using it. NHS England guidance adds that most CBD sold as a supplement is unlicensed, with limited evidence behind it, and that people on medication should be cautious before adding it.

Pregnant or breastfeeding: FSA guidance advises avoiding CBD altogether in this group.
Anyone on prescription medicine: speak to your GP or pharmacist first, especially if your medicine carries a grapefruit warning.
Healthy adults with no medication: start low, around 10-20mg, trial it fairly, and build up gradually to find your level.
Liver conditions: additional caution and liver-function monitoring are sensible, since CBD is processed through the liver.

Pro Tip: Start with the lowest dose your product allows and increase gradually over a period of days, giving your body and your clinician time to spot any change before you go further.

What to do if your medicine has a grapefruit warning

If you’re on a medicine flagged for grapefruit and considering CBD, a bit of preparation before you speak to a clinician makes that conversation far more useful.

Stop any unsupervised CBD use immediately and check your patient information leaflet for the grapefruit warning specifically.
Contact your GP or pharmacist rather than adjusting your prescription dose yourself.
Bring your full medicines list, including anything over the counter, plus details of the CBD product itself: brand, strength and daily dose.
Mention your alcohol intake and any liver history, since both affect how these enzymes behave.
Ask what monitoring might help, such as blood tests or a temporary dose review, before starting.

What the clinician might do	Why it helps
Plasma drug level monitoring	Confirms whether CBD is changing your medicine’s blood concentration
Liver enzyme tests	Checks how your liver is handling both medicine and CBD
Temporary dose adjustment	Compensates for any measured rise or fall in exposure
Supervised trial period	Allows CBD use with oversight instead of guesswork

Our guide on CBD and drug interactions covers how to interpret patient leaflets in more detail if you want to prepare further before your appointment.

How Honest CBD Co supports safer CBD use

We’re a husband-and-wife team in Bolton, and we’ve been making our own CBD in small UK batches since 2018. Our CBD is lab-tested at source and we’re happy to share the certificates of analysis. Just as important for a supervised trial, every product states its strength plainly, so you and your clinician know the dose you’re actually working with rather than guessing from a vague label.

Labels and certificates confirm what’s in a product, but they can’t tell you how CBD will interact with your specific medicine. That question belongs with your GP or pharmacist.
We publish plain-English dosing notes, including guidance for older adults starting CBD, to support a slower, more deliberate trial.
If you’re choosing a product for a supervised trial, pick a brand with a real track record. We’ve traded since 2018, we’re rated Excellent on Trustpilot across 700+ reviews, and we’re glad to answer questions about any product before you order.

Signs that a CBD and medicine interaction may be happening

An interaction doesn’t always announce itself clearly, but certain changes are worth treating as a prompt to stop and check. Unusual drowsiness, dizziness or confusion that wasn’t there before starting CBD can point to a medicine building up beyond its intended level, particularly with sedating drugs like some antiepileptics or antidepressants.

Other signs depend on the medicine class involved. With statins, unexplained muscle pain, tenderness or weakness can signal that levels have risen too high. With immunosuppressants such as tacrolimus, symptoms may be subtler and only show up on a blood test, which is part of why transplant patients are advised to avoid unsupervised CBD use altogether. With blood thinners, easy bruising or unusual bleeding is a warning sign. With blood pressure medicines, lightheadedness or a noticeably slower heart rate can indicate the dose is effectively higher than prescribed.

Changes in how well the medicine seems to be working, rather than side effects appearing, can also be telling. An antidepressant that suddenly feels less effective, or a seizure medicine that stops controlling symptoms as well, might mean CBD has shifted its levels in the other direction through enzyme induction rather than inhibition. None of these signs confirm an interaction on their own, but any of them appearing shortly after starting or increasing CBD is reason enough to contact a pharmacist or GP rather than wait it out.

If you suspect an interaction, here’s what to do

If you notice any of the signs above after starting CBD alongside a medicine that carries a grapefruit warning, stop taking the CBD and contact your GP or pharmacist as soon as you reasonably can. Bring the product with you, or at least its name, strength and how much you’ve been taking, since that detail speeds up any assessment considerably.

Some symptoms warrant faster action. Severe drowsiness, confusion, chest pain, an irregular heartbeat, unusual bleeding or bruising, or any sudden worsening of the condition your medicine is meant to control should be treated as reasons to seek urgent medical help rather than wait for a routine appointment. In the UK, that means contacting NHS 111 for urgent but non-emergency advice, or calling 999 if symptoms are severe or rapidly worsening.

Once things have settled, talk to your clinician about whether monitoring, such as a blood test for drug levels or liver function, would help before restarting CBD, if you restart it at all. Keep a simple note of what you took, how much, and when symptoms began. That record is often more useful to a clinician than a description from memory alone, and it gives them something concrete to work from rather than a guess.

A cautious, practical view

CBD isn’t something to fear, but it isn’t something to combine with a grapefruit-warning medicine on a hunch either. Read the evidence, ask your pharmacist, and let that conversation, not this article, guide your decision. That’s our honest position as a business that sells CBD: we’d rather you check with your pharmacist first and order once you know it’s right for you.

How Honest CBD Co can help you trial CBD more safely

If your GP or pharmacist has given you the go-ahead to try CBD alongside your medicine, the next decision is which product to trust with that dose. A clearly stated strength and a measured format make it far easier to keep your dose consistent and to report exactly what you’re taking.

Our range includes Full Spectrum CBD Oil (10ml, from £25.99), Full Spectrum CBD Capsules and a flavourless Pure CBD Isolate Oil that is THC-free, for those who want to avoid detectable THC altogether.
If you’re not sure which format suits a supervised trial, get in touch and we’ll talk it through; we answer our own emails.
Capsules and measured oils make it easier to keep to a consistent, documented dose, which is useful information to bring back to your clinician.

Have a look through our shop to compare formats and strengths, and get in touch with any questions about a specific product before you order.

Sources

This article draws on clinical trial data for citalopram and tacrolimus, NHS England guidance on cannabis-based products, and peer-reviewed literature on grapefruit-drug interactions. Bring these to your GP or pharmacist when discussing CBD alongside your own medicines.

This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.

FAQ

What should not be mixed with CBD?

Medicines that carry a grapefruit warning, particularly certain statins, immunosuppressants, antiepileptics and antidepressants, are the main ones to be cautious with, since CBD affects some of the same CYP450 enzymes as grapefruit. Always check your patient leaflet or ask a pharmacist before combining CBD with any prescription medicine.

Is CBD harder on the liver than alcohol?

There isn’t a direct comparative study to answer this precisely, so it’s not possible to rank the two reliably. What’s established is that CBD is processed through the liver and can affect liver enzymes, which is why people with liver conditions or those on liver-metabolised medicines are advised to be cautious and monitored.

What drugs have a grapefruit warning?

Common examples include certain statins, calcium channel blockers, immunosuppressants like tacrolimus, some antiarrhythmics and select antiepileptics, largely because these rely on the CYP3A4 enzyme that grapefruit inhibits. Not every drug in these classes carries the warning, so the patient leaflet is the definitive check.